Loading clinical trials...
Loading clinical trials...
Randomized Phase 2 Study of Conventional Dose Chemotherapy Versus High Dose Sequential Chemotherapy as First-line Therapy for Metastatic Poor Prognosis Germ Cell Tumors
Conditions
Interventions
Cyclophosphamide
Etoposide
+3 more
Locations
1
Italy
Istituto Nazionale dei Tumori
Milan, Milano, Italy
Start Date
December 1, 1996
Primary Completion Date
May 1, 2007
Completion Date
April 1, 2009
Last Updated
June 12, 2014
NCT04283773
NCT01055067
NCT02890030
NCT02390843
NCT03726281
NCT00123773
Lead Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions